Brightsurf Science News & Current Events

October 09, 2000
Fred Hutchinson Cancer Research Center's Puget Sound Oncology Consortium to participate in nationwide study to evaluate benefit of Herceptin therapy
Puget Sound Oncology Consortium through the Fred Hutchinson Cancer Research Center is partnering with the National Surgical Adjuvant Breast and Bowel Project, a network of medical professionals funded by the National Cancer Institute (NCI), to launch a new phase III clinical trial that will evaluate Herceptin (Trastuzumab) in the adjuvant setting.

Gene alterations for cystic fibrosis may also account for chronic sinus problems in some
Gene alterations known to cause the inherited disorder cystic fibrosis (CF), which is characterized by mucous membrane abnormalities in the lungs, appear also to contribute to chronic sinus problems in some people, according to a report in this week's Journal of the American Medical Association.

UT Southwestern study shows ThinPrep Pap tests could help develop markers for risk of cervical cancers
A UT Southwestern Medical Center study proves that a recently developed fluid-based Pap test offers a relatively simple way for molecular changes in cell samples to be analyzed.

Driving differentiation of human embryonic stem cells
HHMI researchers have begun to probe the effects that growth factors have on the differentiation of human embryonic stem cells.

One third of epilepsy patients found to have sleep apnea
A third of people with epilepsy may also have undiagnosed sleep apnea, a potentially serious but treatable condition marked by breathing interruptions during sleep.

New computer simulation allows tires to be road tested "virtually" before manufacture
Penn State researchers, in collaboration with the French company ESI Group, have developed a computer simulation that lets engineers

Statement of American Chemical Society President Daryle Busch on the 2000 Nobel Prize in Chemistry
The frontiers of polymer chemistry have been expanded tremendously by the revolutionary work of Drs.

Collecting research data on computer wave of future, UT Southwestern researchers report in JAMA
Secure Internet sites could become an important tool for medical research, according to an article by two UT Southwestern Medical Center at Dallas physicians.

Problem-solvers may be ideal caregivers for children with asthma
To benefit the health of children with asthma, caregivers should possess more than just a basic understanding of asthma facts, suggest the results of a study of inner-city children.

University of Pennsylvania's Alan G. MacDiarmid and former Penn physicist Alan J. Heeger are among three winners of the 2000 Nobel Prize in Chemistry
Alan G. MacDiarmid, Ph.D., Blanchard Professor of Chemistry at the University of Pennsylvania, is one of three recipients of the 2000 Nobel Prize in Chemistry.

UCSF researchers report interventions for victims of domestic violence
A recent study of San Francisco Bay Area physicians reports on successful intervention techniques for victims of domestic violence.

Novartis receives FDA approval for LESCOLĀ® XL 80 mg
Novartis Pharmaceuticals Corporation announces approval by the FDA for LESCOLĀ® XL (fluvastatin sodium) 80 mg, an extended-release tablet formulation of fluvastatin, a therapy that provides effective management of all major lipid parameters for patients with a variety of lipid disorders that place them at risk for heart disease

MS patients susceptible to accelerated mental fatigue
People with multiple sclerosis often complain that they experience both mental and physical fatigue.

Californian wins neuroscience prize endowed by UNC scientist
A California researcher became the first winner of an annual national prize endowed by a distinguished scientist at the University of North Carolina.

First research looks at caregivers' goals for Alzheimer's treatment
The first research to examine how caregivers view Alzheimer's disease treatment shows they rank maintaining the quality - rather than simply the length - of life for Alzheimer's patients, and they are willing to accept risks to slow the disease.

Early oral contraceptive formulations linked to breast cancer risk
Mayo Clinic scientists have found that women with a strong family history of breast cancer who had ever taken oral contraceptives, particularly those introduced prior to 1975, may have a heightened risk of breast cancer. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to